Haystack Health, a Roivant Health company, is the first clinical trial platform purpose-built for value-based care. We partner with health plans, ACOs, sponsors, and health systems to connect patients to clinical trials that improve outcomes, expand access, and reduce cost.
As a rapidly growing, category-defining company, Haystack operates at the intersection of healthcare delivery, payer strategy, and clinical research. Our model brings together payers, trial sponsors, providers, and research sites to unlock access to clinical trials at scale – fundamentally rethinking how patients are identified, engaged, and enrolled.
About Roivant:
Since its inception in 2014, Roivant Sciences has sought to improve health by rapidly delivering innovative medicines and technologies to patients. We’ve employed a unique, decentralized model of nimble, focused companies (‘Vants’) focused on various therapeutic areas and built around the pursuit of innovation in drug development and technology.
Our model is different. Five new medicines have been approved off the Roivant platform; we’ve built five biotechs that have become public; we’ve created well over $1b in value in Roivant Health in just six years. Our successes have ranged from computational drug discovery to tokenized healthcare data exchange, and from novel topicals for dermatological conditions to ultrarare tissue therapies.
Roivant Health is Roivant’s platform for the creation of new technology Vants, focused on delivering improvements to human health outside of our traditional biotech platform. In six years since inception, we’ve created eight enduring companies and over $1B in enterprise value, including the leading deidentified healthcare data exchange platform (Datavant) and a top-tier computational drug discovery company (VantAI) which has partnered with Johnson & Johnson, Bristol-Myers Squibb, and Boehringer Ingelheim. Our goal is to improve human health by rapidly discovering, developing and delivering innovative medicines and technologies to all patients. Our success is predicated on attracting and retaining top talent, generating new ideas and promoting an open and collaborative culture.
Position Location: Remote
Position Summary:
Haystack Health is seeking a Director/VP of Strategy & Operations to lead and scale core operations across our clinical trial programs.
This is a leadership role within a rapidly scaling, high-impact organization. You will own performance across a complex, multi-step clinical operations funnel, driving measurable improvements in patient identification, engagement, and enrollment. You will operate at the intersection of analytics, operations, and execution: diagnosing performance, designing and implementing interventions, and building the systems and teams required to scale.
You will oversee day-to-day operations to understand workflows, identify bottlenecks, and support execution, while also translating these insights into scalable processes, team structures, and operating systems as we grow across clients and geographies.
This is a highly cross-functional leadership role, working closely with clinical, product, and commercial leaders to deliver outcomes for patients and partners, with significant opportunity for growth as the company scales.
Responsibilities:
Skills, Qualifications, and Requirements:
Roivant Sciences provides equal employment opportunities to all employees and applicants for employment and prohibits discrimination and harassment of any type without regard to race, color, religion, age, sex, national origin, disability status, genetics, protected veteran status, sexual orientation, gender identity or expression, or any other characteristic protected by federal, state or local laws.
We will not accept unsolicited resumes nor outreach from agencies. Please do not send agency resumes to our website or Roivant Sciences and affiliated employees. Thanks!

Accela

Dandy

Welo Data Talent

SoundCloud

FWD People